Brief: Puma Biotechnology Q4 Adjusted EPS USD 0.3
26/02/2026 21:05
Feb 26 (Reuters) - Puma Biotechnology Q4 product revenue USD 59.9 million. Q4 net income USD 13.4 million Q4 EPS USD 0.27 Q4 adjusted net income USD 15.1 million
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2